Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» head and neck cancer
head and neck cancer
6 first-half 2024 oncology data readouts to watch
BioSpace
Mon, 02/26/24 - 11:20 am
oncology
clinical trials
Daiichi Sankyo
AstraZeneca
Enhertu
metastatic breast cancer
Gilead Sciences
Trodelvy
bladder cancer
GSK
Zejula
Jemperli
ovarian cancer
Roche
tiragolumab
Tecentriq
non-small cell lung cancer
Cue Biopharma
CUE-101
head and neck cancer
Elicio Therapeutics
ELI-002
solid tumors
Transgene and NEC extend collaboration to develop head and neck cancer vaccine
Biopharma Reporter
Wed, 01/10/24 - 09:20 am
Transgene
NEC
head and neck cancer
clinical trials
TG4050
Adlai Nortye IPO gives old Novartis cancer drug new life
BioPharma Dive
Fri, 09/29/23 - 10:22 am
Adlai Nortye
IPOs
Novartis
AN2025
head and neck cancer
solid tumors
Merck, Eisai Drop Phase III Keytruda-Lenvima Trial for Head and Neck Cancer
BioSpace
Sun, 08/27/23 - 04:40 pm
Merck
Eisai
Keytruda
Lenvima
clinical trials
head and neck cancer
Alentis’ ALE.C04 receives fast track designation from FDA
Pharmaceutical Business Review
Fri, 08/25/23 - 09:44 am
Alentis Therapeutics
FDA
ALE.C04
metastatic head and neck squamous cell carcinoma
head and neck cancer
Galera Lays Off 70% of Staff After FDA Rejection in Severe Oral Mucositis
BioSpace
Thu, 08/10/23 - 11:32 am
Galera Therapeutics
avasopasem manganese
layoffs
oral mucositis
head and neck cancer
FDA
FDA Action Alert: Mesoblast, Sage/Biogen and Galera
BioSpace
Mon, 07/31/23 - 10:05 am
FDA
graft vs host disease
head and neck cancer
postpartum depression
major depressive disorder
Mesoblast
remestemcel-L
Biogen
SAGE Therapeutics
zuranolone
Galera Therapeutics
avasopasem manganese
CEL-SCI's multi-decade Multikine journey extends with FDA request for new trial
Fierce Biotech
Sun, 07/16/23 - 03:08 pm
Cel-Sci
Multikine
head and neck cancer
FDA
clinical trials
J&J Extends Lifeline to Nanobiotix in Potential $1.8B Licensing Deal
BioSpace
Mon, 07/10/23 - 09:36 pm
JNJ
Nanobiotix
NBTXR3
radiotherapy
head and neck cancer
Eisai goes after head and neck cancer in Made of More campaign
Medical Marketing and Media
Mon, 06/12/23 - 11:24 pm
Eisai
head and neck cancer
pharma marketing
ASCO 2023 – Bicara eyes head and neck niche
EP Vantage
Mon, 06/5/23 - 09:59 am
ASCO 2023
Bicara Therapeutics
BCA101
head and neck cancer
Eyeing untapped niche, EpicentRx makes case for cancer toxicity prevention drug
Fierce Biotech
Fri, 01/20/23 - 10:40 am
EpicentRx
clinical trials
head and neck cancer
oral mucositis
RRx-001
Cue's IL-2-based Biologic Shows Early Promise in Head and Neck Cancer
BioSpace
Sun, 11/13/22 - 07:06 pm
Cue Biopharma
CUE-101
head and neck cancer
ESMO: Merck's Keytruda chalks up failure in head and neck cancer. But experts see silver lining
Fierce Pharma
Mon, 09/12/22 - 10:52 am
Merck
Keytruda
head and neck cancer
ESMO
Adaptimmune Reports Positive Data in its SURPASS Trial; Outlines Plans for Advanced Clinical Development in Multiple MAGE-A4 Positive Solid Tumors
Yahoo Finance
Fri, 09/9/22 - 11:03 am
ESMO
Adaptimmune
clinical trials
ADP-A2M4CD8
ovarian cancer
head and neck cancer
urothelial cancer
Merck’s Keytruda fails head and neck cancer trial
CNBC
Wed, 07/20/22 - 09:44 am
Merck
Keytruda
head and neck cancer
clinical trials
Galera's stock plunges 73% on disappointing test results for lead cancer drug candidate
Bizjournals
Tue, 10/19/21 - 10:53 am
Galera Therapeutics
cancer
clinical trials
head and neck cancer
oral mucositis
GC4419
Bristol Myers Squibb takes another late-stage loss for Opdivo-Yervoy combo in head and neck cancer
Endpoints
Fri, 07/16/21 - 10:55 am
Bristol Myers Squibb
Opdivo
head and neck cancer
clinical trials
Cel-Sci's 11-year cancer drug odyssey ends in failure, sinking stock, but plots FDA filing anyway
Fierce Biotech
Tue, 06/29/21 - 11:03 am
Cel-Sci
immunotherapy
clinical trials
head and neck cancer
Multikine
AstraZeneca's Imfinzi Fails To Prolong Survival In Late-Stage Head And Neck Cancer Study
Benzinga
Fri, 02/5/21 - 10:46 am
AstraZeneca
head and neck cancer
Imfinzi
clinical trials
Pages
1
2
3
4
next ›
last »